Head & Neck
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: CT Followed by CRT for Elderly Patients With Advanced Laryngeal Cancer - Evading Surgical Intervention
FEATURING
Maher Salamoon
- 32 views
- December 3, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: H&N Cancer Brief Overview and KEYNOTE-048 Trial Results
FEATURING
Coral Olazagasti
- 57 views
- November 29, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Eftilagimod Alpha + Pembro vs. Pembro in 1L Recurrent/Metastatic HNSCC - TACTI-003 Trial Results Overview
FEATURING
Coral Olazagasti
- 18 views
- November 29, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: ADT vs. Chemo in Recurrent/Metastatic AR-Expressing Salivary Gland Cancer
FEATURING
Coral Olazagasti
- 23 views
- November 29, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Head & Neck Cancer Take Home Messages
FEATURING
Paolo Bossi
- 429 views
- October 8, 2024
- 7
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Head & Neck Cancer Highlights
FEATURING
Nabil Saba
- 359 views
- September 23, 2024
- 5
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: 3-Weekly vs. Weekly Cisplatin in High-Risk HNSCC Post-Op CRT - Final Results of JCOG1008
FEATURING
Makoto Tahara
- 226 views
- September 20, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Avelumab-Cetuximab-RT vs. SoC in Locally Advanced HNSCC - Final Analysis From the REACH Trial
FEATURING
Makoto Tahara
- 158 views
- September 20, 2024
ecancer
ESMO 2024 Insights: EA3163 Trial - Chemo Followed by Surgery & PORT vs. Surgery & PORT for Organ Preservation of T3 & T4a (Selected T4b) Sinonasal Squamous Cell Carcinoma
FEATURING
Nabil Saba
- 91 views
- October 14, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: TACTI-003 - Eftilagimod Alpha + Pembro vs. Pembro Alone in 1L Recurrent/Metastatic HNSCC
FEATURING
Hisham Mehanna
- 21 views
- October 14, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Sequential vs. Induction CT With Concurrent CRT for Locoregionally Advanced Nasopharyngeal Carcinoma
FEATURING
Hisham Mehanna
- 41 views
- October 14, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Neoadjuvant Chemo Followed by Surgery & Post-Operative RT vs. Surgery & Post-Operative RT for Organ Preservation of T3 & T4a Nasal and Paranasal Sinus SCC
FEATURING
Nabil Saba
- 64 views
- September 23, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: GORTEC 2017-01 REACH Trial - Avelumab-Cetuximab-RT vs. Standards of Care in Patients With Locally Advanced SCC of Head & Neck
FEATURING
Yungan Tao
- 66 views
- September 23, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Setanaxib + Pembro in Recurrent or Metastatic HNSCC
FEATURING
Makoto Tahara
- 91 views
- September 20, 2024